Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estrogen for Improvement of Outcomes Following Pelvic Organ Prolapse Surgery
NCT07030426Phase 3Recruiting
- Start
- Jan 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of conjugated estrogens vaginal cream in pelvic organ prolapse (POP). Started Jan 2026; status: recruiting.
02
Drugs
conjugated estrogens vaginal cream
03
Conditions
pelvic organ prolapse (POP)
Beyond the preview
Go deeper on NCT07030426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07030426.